Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
Multiple sclerosis and pregnancy: therapeutic considerations.
Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder.
Fingolimod does not enhance cerebellar remyelination in the cuprizone model.
Country break-out session highlights.
Insights into the channel gating of P2X receptors from structures, dynamics and small molecules.
The insulin-like growth factor system in multiple sclerosis.
2-Cyclopropylimino-3-Methyl-1,3-Thiazoline Hydrochloride Inhibits Microglial Activation by Suppression of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Signaling.
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
Sound Lateralization Test Distinguishes Unimpaired MS Patients from Healthy Controls.
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis.
Efficacy and safety of fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis (FREEDOMS II)
Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica.
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients.
Processing speed and working memory training in multiple sclerosis: A double-blind randomized controlled pilot study.
Peripheral late reactivation of a previously typical monofocal Baló's concentric sclerosis lesion.
Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cord.
Vitamin D in autoimmune liver disease.
Determinants of sexual dysfunction in women with multiple sclerosis.
Benign-onset acute disseminated encephalomyelitis: a report on two cases.
Increasing prevalence and incidence rates of multiple sclerosis in Kuwait.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Treatment of Experimental Autoimmune Encephalomyelitis by Co-Delivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles.
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.
Pages
« first
‹ previous
…
466
467
468
469
470
471
472
473
474
…
next ›
last »